These study findings are particularly timely, with rates of diabetes, obesity, and pancreatic cancer all on the rise. For pancreatic cancer, cases in the EU were found to have increased by 5% between 1990 and 2016, which is the highest increase in the EU’s top five cancers, with the disease anticipated to become the second leading cause of cancer death. Read more . . .
A 20-year analysis presented at UEG Week Virtual 2020 suggested that weight loss surgery significantly decreases the risk of developing pancreatic cancer in individuals who are obese with diabetes.